Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

Digestive diseases and sciences - 1 Jun 1994

Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K

Abstract excerpt

Using conventional statistical analysis and multiple regression analysis, we investigated the viral and host factors that influence the response to recombinant interferon-alpha 2a therapy in patients with chronic hepatitis C. A total of 36 patients was randomly assigned to three administration schedules, 12 patients in each. Response to treatment was set as the criterion variable. Four variables were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Follow-Up Studies
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Molecular Sequence Data

Share to Recombinant Proteins

Share to RNA, Viral

Source

Identifiers

PMID: 8200260
DOI: 10.1007/BF02093793

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.PMID 8200260Read ↗

Analysis of prognostic factors in therapeutic responses to interferon in patients with chronic hepatitis C.Semantic proximity Read ↗

Factors useful in predicting the response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Predictive factors in the response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.Semantic proximity Read ↗

Factors influencing treatment efficacy of 24-week combination therapy with interferon alpha-2b plus ribavirin for chronic hepatitis C.Semantic proximity Read ↗

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.Semantic proximity Read ↗

High-dose natural interferon-alpha therapy for chronic hepatitis C with a high viral load: predictors of efficacy. The Aomori, Akita and Iwate Areas Viral Hepatitis Research Group.Semantic proximity Read ↗

Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.Semantic proximity Read ↗

Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.Semantic proximity Read ↗

Predictive factors of a response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.Semantic proximity Read ↗

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.